Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Merck licenses Coley's VaxImmune vaccine adjuvant

April 17, 2007

Promising preclinical activity of new plant-produced vaccine candidates at Integrated

April 17, 2007

LigoCyte studies norovirus vaccine in phase I trial

April 16, 2007

HuMAb 17C7: a new monoclonal antibody against rabies

April 10, 2007

Start of pivotal trial for Pollinex Quattro ragweed

April 5, 2007

CSL submits BLA for influenza vaccine

April 5, 2007

Rhophylac approved for ITP

April 5, 2007

Novel therapeutic agents for immunological disorders disclosed in recent patents

April 4, 2007

Twinrix approved for new accelerated dosing schedule

April 3, 2007

Plant-derived vaccine adjuvant shows enhanced immune response against hepatitis B in mice

April 3, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...